Interaction of Estradiol and Endoplasmic Reticulum Stress in the Development of Esophageal Carcinoma

Chen Wang,Peng Wang,Jun-Chao Liu,Zhen-Ao Zhao,Rui Guo,Ying Li,Ya-Sen Liu,Shu-Guang Li,Zi-Gang Zhao
DOI: https://doi.org/10.3389/fendo.2020.00410
IF: 6.055
2020-07-22
Frontiers in Endocrinology
Abstract:Gender differences in esophageal cancer patients indicate that estradiol may have antitumor effects on esophageal cancer. The initiation of endoplasmic reticulum stress (ERS) can induce apoptosis in esophageal cancer cells. However, it is still unknown whether estradiol inhibits the development of esophageal cancer by activating ERS pathway. In this study, the gender difference in the development of esophageal cancer was observed by analyzing clinical data and the experimental tumor xenografts in mice. Meanwhile, we investigated the mechanism of ERS in estradiol-mediated inhibition of esophageal cancer using esophageal squamous cell carcinoma cell line EC109. The proportion of male patients with esophageal cancer was significantly higher than female patients. Meanwhile, male patients were prone to have adventitial invasion. The weight of transplanted tumors in female mice was significantly smaller than that in male mice. <i>In vitro</i> experiments showed estradiol inhibits the viability and migration of EC109 cells by increasing the expression of ERS-related proteins, whereas ERS inhibitor 4-PBA abolished the effects of estradiol. In conclusion, our data demonstrate that sex difference exists in the occurrence of esophageal cancer. Estradiol can inhibit the viability and migration of esophageal cancer cells through the activation of ERS, providing a novel insight for esophageal cancer development, treatment, and prevention.
endocrinology & metabolism
What problem does this paper attempt to address?
The paper aims to explore the interaction between estradiol and endoplasmic reticulum stress (ERS) in the development of esophageal cancer, and to study the impact of gender differences on the occurrence of esophageal cancer. Specifically, the paper addresses the following key issues: 1. **Gender Differences**: Through the analysis of clinical data, it was found that the proportion of male esophageal cancer patients is significantly higher than that of female patients, and the tumors in male patients are more aggressive. 2. **Mechanism of Estradiol**: Through cell experiments, it was found that estradiol can inhibit the proliferation and migration ability of the esophageal cancer cell line EC109 by increasing the expression of ERS-related proteins. 3. **ERS Signaling Pathway**: The paper further explores the specific molecular mechanisms by which estradiol activates the ERS signaling pathway, including the upregulation of proteins such as GRP78, ATF6, IRE1α, and PERK. In summary, the main purpose of the paper is to reveal how estradiol inhibits the development of esophageal cancer through the ERS pathway and to provide a new therapeutic perspective.